본문 바로가기
KERD
논문KCI 등재

Isolation of a Klebsiella pneumoniae Isolate of Sequence Type 258 Producing KPC-2 Carbapenemase in Korea

0

조회

0

다운로드

8

인용

0

참고문헌

키워드

주제분류병리학

초록

Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.

Abstract

Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.

참고문헌 (23)

  1. Nordmann P, "Emerging carbapenemases in Gram-negative aerobes", Clin Microbiol Infect, 8, pp.321~331 (2002)
  2. Queenan AM, "Carbapenemases: the versatile β-lactamases", Clin Microbiol Rev, 20, pp.440~458 (2007)
  3. Nordmann P, "The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria", Lancet Infect Dis, 9, pp.228~236 (2009)
  4. Yigit H, "Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae", Antimicrob Agents Chemother, 45, pp.1151~1161 (2001)
  5. Giakkoupi P, "Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases", Antimicrob Agents Chemother, 53, pp.4048~4050 (2009)
  6. Navon-Venezia S, "First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States", Antimicrob Agents Chemother, 53, pp.818~820 (2009)
  7. Samuelsen Ø, "Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden", J Antimicrob Chemother, 63, pp.654~658 (2009)
  8. Villegas MV, "First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America", Antimicrob Agents Chemother, 50, pp.2880~2882 (2006)
  9. Wei ZQ, "Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China", Antimicrob Agents Chemother, 51, pp.763~765 (2007)
  10. Rhee JY, "KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea", Antimicrob Agents Chemother, 54, pp.2278~2279 (2010)
  11. Pournaras S, "Detection of the new metallo-β-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae", J Antimicrob Chemother, 65, pp.1604~1607 (2010)
  12. Marchaim D, "Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes", Antimicrob Agents Chemother, 52, pp.1413~1418 (2008)
  13. Lee K, "Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli", J Microbiol Methods, 83, pp.149~152 (2010)
  14. "Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 57, pp.315~318
  15. Giske CG, "A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin", Clin Microbiol Infect, 17, pp.552~556 (2011)
  16. Patzer JA, "Emergence and persistence of integron structures harbouring VIM genes in the Children’s Memorial Health Institute, Warsaw, Poland, 1998-2006", J Antimicrob Chemother, 63, pp.269~273 (2009)
  17. Smith Moland E, "Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates", J Antimicrob Chemother, 51, pp.711~714 (2003)
  18. Zarfel G, "Emergence of New Delhi metallo-β-lactamase, Austria", Emerg Infect Dis, 17, pp.129~130 (2011)
  19. Diancourt L, "Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates", J Clin Microbiol, 43, pp.4178~4182 (2005)
  20. Park YJ, "Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli", Diagn Microbiol Infect Dis (2011)
  21. Kitchel B, "Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258", Antimicrob Agents Chemother, 53, pp.3365~3370 (2009)
  22. Cai JC, "Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital", Antimicrob Agents Chemother, 52, pp.2014~2018 (2008)
  23. Anderson KF, "Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae", J Clin Microbiol, 45, pp.2723~2725 (2007)

관련 논문AI추천

MCR1 and KPC2 Co-producing Klebsiella pneumoniae Bacteremia: First Case in Korea권기태, 박지영, 송도영, 이광준, 최지애, 허상택대한감염학회 · Infection and Chemotherapy2019 · 제51권 제4호Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea김재석, 김한성, 김현수, 박민정, 송원근, 신동훈, 신새암, 이승순, 정석훈, 홍준성대한진단검사의학회 · Annals of Laboratory Medicine2016 · 제36권 제6호Phenotypic and Genomic Characterization of AmpCProducing Klebsiella pneumoniae From Korea박연준, Alex van Belkum, Andreu Coello Pelegrin, Caroline Mirande, Christine Franceschi, Mattia Palmieri, Sonia Chatellier, Stephane Schicklin대한진단검사의학회 · Annals of Laboratory Medicine2018 · 제38권 제4호국내 종합병원에서 발생한 KPC-2 생성 Klebsiella pneumoniae 집단 발생에 대한 역학 분석 연구김건한, 김도균, 박별이, 이경화, 정석훈, 조난형, 홍준성대한임상미생물학회 · Annals of Clinical Microbiology2020 · 제23권 제2호An Increase in the Clinical Isolation of Acquired AmpC β-Lactamase-Producing Klebsiella pneumoniae in Korea from 2007 to 2010김재석, 김택경, 김한성, 박민정, 송원근, 이재갑대한진단검사의학회 · Annals of Laboratory Medicine2013 · 제33권 제5호Outbreak of Imipenemase-1-Producing Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit김제훈, 박지영, 양희영, 유정식, 이영희, 이진영대한중환자의학회 · Acute and Critical Care2017 · 제32권 제1호

이 간행물의 다른 논문 (15건)